PRX-08066, soluble in DMSO, ethanol and water, inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets 5-HT2B receptor.
PRX-08066 can be used for its ability to inhibit the proliferation of smooth muscle cells in the pulmonary arteries and improve pulmonary hemodynamics.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.